Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects

Area of Science:

• Oncology
• Immunology
• Metabolic Research

Background:

• Sarcomas are rare but aggressive malignancies with limited immunotherapy advances.
• Understanding the systemic immune environment in sarcoma is crucial for developing effective treatments.
• Obesity is a significant health concern that may influence cancer progression.

Purpose of the Study:

• To analyze the systemic immune environment in treatment-naive sarcoma patients.
• To investigate the impact of obesity on serum protein profiles in sarcoma.
• To identify potential therapeutic targets by characterizing protumorigenic factors.

Main Methods:

• Multiplex analysis of serum cytokines, chemokines, and protumorigenic factors.
• Comparison of protein profiles between sarcoma patients and tumor-free controls.
• Correlation analysis of serum factors with body mass index in sarcoma patients.

Main Results:

• Sarcoma patients exhibited increased levels of epidermal growth factor (EGF), angiopoietin-2, vascular endothelial growth factor A (VEGF-A), IL-6, IL-8, and MIP-1β compared to controls.
• Obesity was associated with decreased levels of EGF and IL-8, and reduced Th2 cytokines (IL-4, IL-5, IL-13).
• Obesity did not exacerbate the protumorigenic systemic environment in sarcoma patients.

Conclusions:

• The systemic environment in sarcoma patients is altered to favor tumor progression.
• Obesity does not appear to worsen the protumorigenic profile in this sarcoma cohort.
• Further research is needed to elucidate the complex interplay between sarcoma, immunity, and metabolic factors.